P154 GETTING OPTIMAL AND TARGET BLOOD PRESSURE IS MORE CHALLENGING FOR HYPERTENSIVE PATIENTS WITH ANOTHER CARDIOVASCULAR DISEASE

Home blood pressure monitoring (HBPM) compared with office-based monitoring could be better at predicting cardiovascular morbidity and mortality. Patients and Methods: This project aimed to evaluate HBPM in adult pts with AH. It was conducted from April to June 2022 at 178 general physicians practices in Slovakia. Results: 4375 pts with AH were enrolled (2089 women, 51,8%), mean age 61,1 ± 19,1 years. BP values at HBPM decreased over the period of seven days by -2.2/-1.4 mm Hg (p < 0.01). The first treatment goal, office BP ≤ 140/90 mm Hg, was achieved by 67% of patients. The second treatment goal, based on patients’ age was achieved by 35% of patients. The number of patients with CV comorbidities surpassed 48.8%. They were significantly older 67,3± 15,2 years vs 57,1 ± 12,6 years (p<0,01), with a higher BMI of 30,1± 5,2 kg/m2vs 28,7 ± 3,8 kg/m2 (p<0,01) in comparison with patients without CV comorbidities. In HBPM patients with CV comorbidities have higher both systolic BP (SBP) and diastolic BP (DBP) 134,8 ± 11,2/80,3± 7,6 mmHg vs 131,9±8,2/80,4 ±6,4 mmHg (p<0,01). To compare with office blood pressure measurements: higher SBP was in patients with CV comorbidities 137,1 ±18,1 mmHg vs 135,2 ±16,3 mmHg (p 0,516), higher DBP was in patients without CV comorbidities 81,5 ±6,4 mmHg vs 80,3 ± 5,1 mmHg (p<0,01). Dyslipidemia was present in 67% of patients. Women were more likely to have dyslipidemia and hypertension 68,8% vs 65,5% (p=0.03) in men. Conclusions: The results of office and home BPM 2022 demonstrated active involvement of patients in the management of AH can have a significant impact. We need to be more consistent in treating AH, according to 2023 ESH guidelines, mainly in patients with cardiovascular comorbidities. By achieving a 67% success rate in control of AH patients, The Charter 70/2023 is imminent.